tiprankstipranks
Trending News
More News >
ADJUVANT HOLDINGS CO., LTD. (JP:4929)
:4929
Japanese Market
Advertisement

ADJUVANT HOLDINGS CO., LTD. (4929) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4929

ADJUVANT HOLDINGS CO., LTD.

(4929)

Rating:60Neutral
Price Target:
¥811.00
▲(6.01% Upside)
The overall stock score is primarily influenced by the company's strong balance sheet and liquidity position, which provide stability. However, the high P/E ratio suggests overvaluation, and the technical indicators point to a neutral trend. Revenue growth challenges and inconsistent cash flow growth are significant concerns.

ADJUVANT HOLDINGS CO., LTD. (4929) vs. iShares MSCI Japan ETF (EWJ)

ADJUVANT HOLDINGS CO., LTD. Business Overview & Revenue Model

Company DescriptionADJUVANT HOLDINGS CO., LTD. (4929) is a company engaged in the development, manufacturing, and sale of cosmetics and skincare products. The company operates in the beauty and personal care sector, providing a range of high-quality products designed to enhance beauty and skin health. Its core offerings include facial care, body care, and hair care products, catering to a diverse consumer base seeking effective and innovative skincare solutions.
How the Company Makes MoneyADJUVANT HOLDINGS CO., LTD. generates revenue primarily through the sale of its cosmetics and skincare products. The company employs a multi-channel sales strategy, distributing its products through direct sales, retail outlets, and online platforms. It also leverages partnerships with beauty salons and spas to expand its market reach and brand presence. The company's revenue streams are bolstered by its commitment to research and development, ensuring a steady pipeline of new and improved products that meet consumer demands for quality and effectiveness.

ADJUVANT HOLDINGS CO., LTD. Financial Statement Overview

Summary
ADJUVANT HOLDINGS CO., LTD. demonstrates a strong balance sheet with minimal leverage and a solid equity position. While profitability has improved, revenue trends are concerning, and cash flow growth has been inconsistent. The company shows potential for stability with its efficient cost management and strong liquidity, but needs to address revenue growth challenges.
Income Statement
65
Positive
The income statement shows a volatile revenue trend with a decline in recent years. The gross profit margin remains strong at approximately 64.8% for 2025, indicating efficient cost management. However, net profit margins have been inconsistent, with a significant improvement to 1% in 2025 from negative figures in prior years. EBIT and EBITDA margins have also improved, reflecting better operational efficiency, but the overall revenue decline is a concern.
Balance Sheet
75
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.007, indicating minimal leverage and financial risk. The equity ratio is high at 79%, showcasing a solid capital structure. Return on equity improved to 0.97% in 2025, recovering from negative returns in previous years. The company maintains a robust liquidity position with substantial cash reserves.
Cash Flow
70
Positive
Cash flow analysis reveals a stable operating cash flow, with a positive free cash flow in 2025. The free cash flow to net income ratio is high, suggesting efficient cash generation relative to net income. However, the free cash flow growth rate is negative compared to 2024, indicating potential challenges in sustaining cash flow growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.10B4.10B4.44B4.38B4.43B4.89B
Gross Profit2.66B2.66B2.86B2.92B2.94B3.00B
EBITDA244.00M259.63M124.00M341.54M500.79M292.22M
Net Income40.69M40.73M-99.86M403.64M393.18M142.38M
Balance Sheet
Total Assets5.29B5.29B5.28B5.55B5.66B5.10B
Cash, Cash Equivalents and Short-Term Investments2.22B2.22B2.12B1.53B1.74B1.47B
Total Debt30.51M30.51M30.82M19.18M30.08M22.96M
Total Liabilities1.11B1.11B1.06B1.06B1.34B1.00B
Stockholders Equity4.18B4.18B4.22B4.49B4.32B4.09B
Cash Flow
Free Cash Flow0.00301.91M314.89M-422.66M369.44M317.90M
Operating Cash Flow0.00307.99M377.61M-321.67M417.88M403.11M
Investing Cash Flow0.00-95.61M391.20M344.97M24.39M-235.19M
Financing Cash Flow0.00-104.55M-198.21M-256.90M-179.73M-169.56M

ADJUVANT HOLDINGS CO., LTD. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price765.00
Price Trends
50DMA
768.88
Negative
100DMA
766.47
Negative
200DMA
787.47
Negative
Market Momentum
MACD
-0.70
Negative
RSI
49.76
Neutral
STOCH
27.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4929, the sentiment is Neutral. The current price of 765 is above the 20-day moving average (MA) of 762.60, below the 50-day MA of 768.88, and below the 200-day MA of 787.47, indicating a neutral trend. The MACD of -0.70 indicates Negative momentum. The RSI at 49.76 is Neutral, neither overbought nor oversold. The STOCH value of 27.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4929.

ADJUVANT HOLDINGS CO., LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥40.61B28.40
1.45%6.10%13.84%
65
Neutral
¥10.87B53.01
2.22%4.75%-83.63%
63
Neutral
¥6.61B10.33
2.29%-3.27%
63
Neutral
$20.44B14.73-2.84%3.14%2.04%-6.12%
60
Neutral
¥6.15B159.35
1.57%-9.81%
56
Neutral
¥7.79B10.68
-17.95%
45
Neutral
¥5.15B20.42
1.66%7.21%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4929
ADJUVANT HOLDINGS CO., LTD.
765.00
-76.67
-9.11%
JP:4923
Cota Co., Ltd.
1,381.00
-272.54
-16.48%
JP:4925
HABA Laboratories, Inc.
1,748.00
-208.87
-10.67%
JP:4926
C'BON COSMETICS Co., Ltd.
1,203.00
-94.92
-7.31%
JP:4934
Premier Anti-Aging Co., Ltd.
893.00
84.00
10.38%
JP:4936
AXXZIA, Inc.
451.00
-350.35
-43.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 26, 2025